Call for Abstracts - VPH Research to Business Session

8-9 September 2010, Barcelona, Spain.
The vision of the Virtual Physiological Human is a grand challenge. A key feature of the VPH initiative is the promise of some low-hanging fruits, applications where the power of multiscale simulation technology can be placed into clinical and industrial practices in the not-so-distant future. Viewed in this light, it is essential for all VPH projects to actively disseminate their research results towards the biomedical industry.

For the second year, the VPH Network of Excellence is organising a two-day meeting where the VPH community showcases its best results to the biomedical industry. This is not only to increase the exploitation potential of VPH research, but also to expand the take-on of VPH technologies in the health industry.

This year the program revolves around three types of sessions:

  • Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
  • Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
  • Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

  • Ensuring that industrial partners of your consortia are informed of the event and are motivated to send delegates
  • Explore with their industrial partners or spin-offs the interest to present their products and services at the B2B session. Those interested should contact Elena Villalba Mora, This email address is being protected from spambots. You need JavaScript enabled to view it..
  • Submit an abstract of the presentation on the best research results they would like to showcase in the R2B session.

Selection Criteria
The draft programme consists of 12 slots of 30-minutes for each presentation. In the event that abstracts received are more than the number of available slots, the organisation of the event will make a selection according to the following criteria:

  • Fair representation of all projects (if two abstracts come from the same project one might be excluded)
  • Broadest possible coverage of the clinical and industrial domains
  • Closeness of results to be presented to the industrial/clinical exploitation

Consortia and research groups who wish to present, should follow the instructions below.

Submission of Abstracts
Your abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.

Instructions for Submission of Abstracts
Please send your abstract to Vanessa Diaz, This email address is being protected from spambots. You need JavaScript enabled to view it. Abstracts will be between 350 and 500 words long, without including the title and the authors. The format is free; feel free to include illustrations.

Abstract Contents
Abstracts should cover the following topics:

  • Subject of research
  • Clinical and/or industrial translation
  • Clinical uptake
  • Development of tools if any

Evaluation
The event organisers will evaluate all abstracts. Notification of acceptance will be provided the last week of April.

For further information, please visit:
http://www.vph-noe.eu

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.

Most Popular Now

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

The Bristol-Myers Squibb-Pfizer Alliance…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib)...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...

Using Artificial Intelligence to Predict…

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of...

Bayer Launches LifeHub UK Focused on Art…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network...

AI could Offer Warnings about Serious Si…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at...

NHS Health Tech Team of the Year Named

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North...

Philips and Klinikum Stuttgart Hospital …

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership...

Heartbeat Labs Hired Babylon Health's Ch…

The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection...

Combination of AI & Radiologists mor…

An artificial intelligence (AI) tool - trained on roughly a million screening mammography images - identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists, a...

Abbott and Omada Health Partner to Offer…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care...

First Entirely Digital Clinical Trial En…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study. The...